 |
|
Journal articles
Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin
W Tse
Author
F. Gouilleux 3
Mail :
Author IdHAL : fabrice-gouilleux ORCID : https://orcid.org/0000-0001-6047-1718
R Moriggl
Author
K Bunting
Author
1
Taiyuan University of Technology (Taiyuan Shangxi province China 030024 - China)
2
State Key Laboratory of Marine Geology [Shanghai] (China)
- Tongji University (1239 Siping Road, Shanghai - China)
3
GICC UMR 6239 CNRS - Génétique, immunothérapie, chimie et cancer (GICC), UMR 6239 CNRS [2008-2011] (UFR de Médecine, Bâtiment Bretonneau, 10 boulevard Tonnellé, BP 3223, 37032 Tours Cedex 01 - France)
- Université de Tours (60 rue du Plat d'Étain, 37020 Tours cedex 1 - France)
- CNRS - Centre National de la Recherche Scientifique (France)
Domain :
Complete list of metadatas
https://hal-univ-tours.archives-ouvertes.fr/hal-02424599
Contributor : Fabrice Gouilleux <>
Submitted on : Friday, December 27, 2019 - 6:54:59 PM
Last modification on : Friday, January 3, 2020 - 4:48:06 PM
Contributor : Fabrice Gouilleux <>
Submitted on : Friday, December 27, 2019 - 6:54:59 PM
Last modification on : Friday, January 3, 2020 - 4:48:06 PM
Links full text
Identifiers
- HAL Id : hal-02424599, version 1
- DOI : 10.1038/leu.2010.131
Collections
Citation
G Li, K Miskimen, Z. Wang, X. Xie, W Tse, et al.. Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (8), pp.1397-1405. ⟨10.1038/leu.2010.131⟩. ⟨hal-02424599⟩
Metrics
Record views
